Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BGBA-445 by BeiGene for Solid Tumor: Likelihood of Approval
BGBA-445 is under clinical development by BeiGene and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
BGBA-445 by BeiGene for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
BGBA-445 is under clinical development by BeiGene and currently in Phase II for Squamous Non-Small Cell Lung Cancer. According to...
BGBA-445 by BeiGene for Nasopharyngeal Cancer: Likelihood of Approval
BGBA-445 is under clinical development by BeiGene and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase II...